Background illustration for clinical trials search

Paid Clinical Trials Annapolis

Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,396

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

for

Advanced Solid Tumors, Metastatic Pancreatic Cancer,

Location: Bethesda MD, Fairway KS

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT04222413

Phase1, Recruiting

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

for

Costello Syndrome, Noonan Syndrome,

Location: Bethesda MD, Rockville MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 70+

Code: NCT04888936

Recruiting

Clinical and Molecular Studies in Families With Inherited Eye Disease

for

Inherited Eye Disease

Location: Bethesda MD, La Jolla CA

Sponsor: National Eye Institute (NEI)

Sex: All

Age: 4 - 70+

Code: NCT02771236

Recruiting

Effects of Treatments on Atopic Dermatitis

for

Eczema, Dermatitis, Skin Diseases, Genetic, Dermatitis, Atopic,

Location: Bethesda MD

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: All

Age: 2 - 50

Code: NCT01631617

Phase2, Recruiting

Study of Chediak-Higashi Syndrome

for

Chediak-Higashi Syndrome

Location: Bethesda MD

Sponsor: National Human Genome Research Institute (NHGRI)

Sex: All

Age: 0 - 70

Code: NCT00005917

Recruiting

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

for

Attention Deficit Hyperactivity Disorder

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 8 - 16

Code: NCT05608434

Phase1, Phase2, Recruiting

Men at High Genetic Risk for Prostate Cancer

for

Prostatic Neoplasms

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 30 - 70+

Code: NCT03805919

Recruiting

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

for

Kidney Transplant Rejection

Location: Baltimore MD, New York NY, The Bronx NY, Columbus OH,

Sponsor: Sanofi

Sex: All

Age: 18 - 70

Code: NCT07412470

Phase2, Phase3, Recruiting

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

for

Glioma, Medulloblastoma, Ependymoma, Glioblastoma

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06161519

Phase1, Phase2, Recruiting

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

for

Polymyalgia Rheumatica

Location: Rockville MD, Hagerstown MD, Wyomissing PA,

Sponsor: Sanofi

Sex: All

Age: 50+

Code: NCT07286214

Recruiting

Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets

for

Meniere's Disease, Enlarged Vestibular Aqueduct Syndrome,

Location: Bethesda MD

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All

Age: 18 - 70+

Code: NCT04806282

Recruiting

Crownlands Observing Progression With Neurons Study

for

Alzheimer s Disease, Mild Cognitive Impairment (MCI)

Location: Germantown MD

Sponsor: Crownlands

Sex: All

Age: 55+

Code: NCT07611396

Recruiting

Evaluation of [11C]ZTP-1 to Image PDE4B

for

Healthy

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70+

Code: NCT07625345

Phase1, Recruiting

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

for

Peripheral Blood Stem Cell Transplantation,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT05436418

Phase1, Phase2, Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

for

Pancreatic Cancer, Gastric Cancer, Gastrointestinal Cancer,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03190941

Phase1, Phase2, Recruiting

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

for

KSHV Inflammatory Cytokine Syndrome (KICS),

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06052618

Phase2, Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

for

Focal Seizure, Epilepsy, Focal Epilepsy

Location: Bethesda MD, Philadelphia PA, Richmond VA,

Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07563881

Phase3, Recruiting

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

for

Recurrent Glioblastoma,

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT07416188

Phase1, Phase2, Recruiting

Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging

for

Normal and Abnormal Cardiovascular Physiology

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 7 - 70+

Code: NCT03581318

Recruiting

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

for

Acute Lymphoblastic Leukemia, B-All

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 65

Code: NCT07328503

Phase2, Recruiting

Paid Clinical Trials Annapolis

Filter results

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

Clinical and Molecular Studies in Families With Inherited Eye Disease

Effects of Treatments on Atopic Dermatitis

Study of Chediak-Higashi Syndrome

Interested in new trials?

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

Men at High Genetic Risk for Prostate Cancer

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets

Crownlands Observing Progression With Neurons Study

Evaluation of [11C]ZTP-1 to Image PDE4B

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia